Processing Your Payment
Please do not leave this page until complete. This can take a few moments.
Research & Development
-
Former GlaxoSmithKline CEO joins Framingham biopharma board
December 10, 2015Jean-Pierre Garnier has been appointed chairman of the board of Alzheon Inc., a Framingham-based private biopharmaceutical startup focused on developing treatments for Alzheimer’s disease.
December 10, 2015
Ocata results show promise for lupus treatment
December 3, 2015Results published in the journal Scientific Reports suggest that Marlborough-based Ocata Therapeutics has developed technology that can be used to prevent lupus nephritis, a fatal complication in patients with lupus.
December 3, 2015
WPI team creates virtual human
November 4, 2015Engineers at Worcester Polytechnic Institute have developed a virtual human by digitizing and combining high-resolution images of thin slices of an actual human body, WPI announced Tuesday.
November 4, 2015
October 22, 2015
Mevion beams in on cancer treatment
September 28, 2015In 2007, he met with Still River Systems (renamed Mevion Medical Systems in 2011), to seek to solve the problem.
September 28, 2015Sunovion extends development agreement
September 14, 2015Marlborough-based Sunovion Pharmaceuticals has extended a drug discovery and development agreement with a New York company.
September 14, 2015ALS researchers at UMass Medical get ‘Ice Bucket’ funds
September 3, 2015Two groups of scientists at the University of Massachusetts Medical School have each received $1 million in grant money raised during last summer's viral Ice Bucket Challenge campaign, funds that will support ALS research projects that the school's
September 3, 2015Cambridge biopharma announces research agreement with UMass Medical School
August 27, 2015Cambridge-based biopharmaceutical company Enumeral Biomedical Holdings has announced a research study agreement with the University of Massachusetts Medical School to aid the company in developing new cancer therapies.
August 27, 2015Waters Corp. names new CEO
June 26, 2015Christopher J. O'Connell will take on the role of chief executive officer at Waters Corp. beginning in September.
June 26, 2015Ocata Therapeutics prices $30 million common stock offering
June 17, 2015Marlborough's Ocata Therapeutics is expecting to net over $30 million in a stock offering, after the company announced pricing for the stock Wednesday.
June 17, 2015Philips to move operations from N.Y. to Cambridge
May 20, 2015The international lighting company Royal Philips, which has operations in Framingham, has signed a $25 million research agreement with MIT and will move its North American research center from New York to Cambridge's Kendall Square.
May 20, 2015NIH funds WPI heart valve study
April 23, 2015Research at Worcester Polytechnic Institute aimed at creating more natural and durable replacement heart valves is getting a boost from the National Institutes of Health, the school announced Wednesday.
April 23, 2015
AMSC stock soars following likely Navy deal
April 22, 2015Stock in Devens-based AMSC shot up more than 30 percent this week after the company announced expanded relationships with both the U.S. Navy and energy provider Eversource.
April 22, 2015Oxford Immunotec launches T cell test
April 1, 2015Oxford Immunotec of Marlborough has developed a laboratory test that measures a patient's immunity to cytomegalovirus (CMV), a herpes virus.
April 1, 2015RXi grows 4Q revenue, cuts losses
March 30, 2015RXi Pharmaceuticals of Marlborough, which is pushing toward federal approval of its initial products, saw 8.3-percent revenue growth in the final quarter of 2014 while paring its quarterly loss over the fourth quarter of 2013.
March 30, 2015
March 30, 2015
WBJ Web partners
Most Recent
